Svjetlana Loga-Zec
University of Sarajevo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Svjetlana Loga-Zec.
Archive | 2012
Nedzad Mulabegovic; Jasna Kusturica; Maida Todić-Rakanović; Mirjana Mijanović; Fahir Bečić; Asija Zaciragic; Selma Škrbo; Lejla Burnazović-Ristić; Aida Kulo; Svjetlana Loga-Zec
Enkorten is a new potential drug for the treatment of rheumatoid arthritis, with an immunomodulatory and anti-inflammatory effect. It is a combination of two peptide components of endogenous origin: methionine-enkephalin of 5 mg and tridecactide of 1 mg (Picture 1 and 2). According to the chemical structures, these components correspond to amino acid sequences of the neuropeptide precursor proopiomelanocortin.
Psychiatria Danubina | 2010
Slobodan Loga; Svjetlana Loga-Zec; Mira Spremo
Psychiatria Danubina | 2010
Svjetlana Loga-Zec; Slobodan Loga
Psychiatria Danubina | 2011
Svjetlana Loga-Zec; Slobodan Loga
Bosnian Journal of Basic Medical Sciences | 2005
Saida Fišeković; Svjetlana Loga-Zec
Psychiatria Danubina | 2009
Slobodan Loga; Svjetlana Loga-Zec
Bosnian Journal of Basic Medical Sciences | 2002
Jasna Kusturica; Irfan Zulić; Svjetlana Loga-Zec; Nedžad Mulabegović; Slobodan Loga; Elvedina Kapić
Chromatographia | 2014
Aida Kulo; Nedzad Mulabegovic; Svjetlana Loga-Zec; Karel Allegaert; Jan de Hoon; René Verbesselt
Psychiatria Danubina | 2011
Slobodan Loga; Svjetlana Loga-Zec; Bojan Šošić
Psychiatria Danubina | 2010
Slobodan Loga; Svjetlana Loga-Zec
